| 4-OHT | 4-hydroxytamoxifen |
| ACD | accidental cell death |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| ARNT | aryl hydrocarbon receptor nuclear translocator |
| ATP | adenosine triphosphate |
| BAD | bcl2-associated agonist of cell death |
| BAK | bcl-2 homologous antagonist killer |
| BAX | bcl-2 associated X protein |
| Bcl-XL | B-cell lymphoma-extra large |
| BID | BH3 interacting-domain death agonist |
| CaCO3 | calcium carbonate |
| CaP | calcium phosphate |
| CaMKIIγ | calcium/calmodulin-stimulated protein kinase II |
| CBD | cannabidiol |
| cfDNA | cell-free DNA |
| CHOP | C/EBP homologous protein |
| CK1α | casein kinase 1α |
| CREB | cAMP-responsive element binding protein |
| CYLD | cylindromatosis |
| DAMP | damage-associated molecular pattern |
| DHPR | dihydropyridine receptor |
| EMRE | essential MCU regulator |
| ER | endoplasmic reticulum |
| ERK | extracellular signal-regulated kinase |
| ERO1-α | ER oxidase 1 alpha |
| FADD | FAS-associated death domain protein |
| FasL | Fas ligand |
| FasR | Fas receptor |
| GPX4 | glutathione peroxidase 4 |
| HER-2 | receptor tyrosine-protein kinase erbB |
| HIF1-α | hypoxia-inducible factor 1 alpha |
| HMGB1 | high mobility group box 1 |
| iASPP | inhibitor of apoptosis stimulating protein of P53 |
| IP3R | inositol triphosphate receptor |
| KAE | kaempferol-3-O-rutinoside |
| LSCs | leukemia stem cells |
| MAPK | mitogen-activated protein kinase |
| MCU | mitochondrial calcium uniporter |
| MICU1/2 | mitochondrial calcium uptake proteins ½ |
| MFN2 | mitofusin-2 |
| MiST | mitochondrial shape transition |
| Miro1 | mitochondrial rho GTPase 1 |
| MLCK | myosin light chain kinase |
| MLKL | lineage kinase domain-like protein |
| mPTP | mitochondrial permeability transition pore |
| mTOR | rapamycin-dependent protein kinase |
| NIR | near-infrared |
| NFAT1 | nuclear factor of activated T cells 1 |
| NLRP3 | NACHT, LRR, and PYD domains-containing protein 3 |
| NRF2 | nuclear factor erythroid 2-related factor 2 |
| ORAI1 | calcium release-activated calcium channel protein 1 |
| P2XR4 | purinergic receptor 4 |
| PARP | poly ADP-ribose polymerase |
| PD-L1 | programmed death-ligand 1 |
| PET/MRI | positron emission tomography/magnetic resonance imaging |
| PI3K | phosphoinositide 3-kinase |
| Piezo1 | piezo type mechanosensitive ion channel component 1 |
| PKC | protein kinase C |
| PMCA | plasma membrane calcium ATPases |
| PS | phosphatidylserine |
| RCD | regulated cell death |
| RIPK | receptor-interacting protein kinase |
| RLC | myosin regulatory light chain |
| ROS | reactive oxygen species |
| RyR | ryanodine receptor |
| SERCA | sarcoplasmic/endoplasmic reticulum Ca2+-ATPase |
| SNARE | synaptobrevin, syntaxin, and SNAP-25 complex |
| SOCE | store-operated calcium entry |
| STIM1 | ER stromal interaction molecule 1 |
| STP | stemphol |
| TFEB | transcription factor EB |
| TIL | tumor-infiltrating lymphocyte |
| TLR4 | toll-like receptor 4 |
| TNBC | triple-negative breast cancer |
| TNF-α | tumor necrosis factor α |
| TNFR1 | tumor necrosis factor receptor 1 |
| TRADD | TNFR1-associated death domain protein |
| TRPC4 | transient receptor potential calcium channel C4 |
| TRPM7 | transient receptor potential melastatin 7 |
| TRPV1 | transient receptor potential cation channel subfamily V member 1 |
| TRPV4 | transient receptor potential cation channel subfamily V member 4 |
| UCNPs | upconversion nanoparticles |
| VDAC | voltage-dependent anion channel |
| ZIF-82 | zeolite framework of nitro-/nitrilo-imidazole |